From the Journals

Fluorescent Imaging Demystifies Melanoma

Study validates non-invasive molecular imaging device for point-of-care assessment of suspicious moles

Share

A novel skin fluorescent imaging (SFI) system has shown promise for non-invasive, point-of-care molecular testing of challenging pigmented lesions, as confirmed by a study published in the Journal of the American Academy of Dermatology. This system has the potential to minimize unnecessary biopsies and enhance early detection of aggressive cancers. By integrating molecular data with traditional evaluation methods, dermatologists can better identify lesions at risk of melanoma, providing a significant advancement in melanoma care.

Original Source(s)

Fluorescent Imaging Demystifies Melanoma

Study validates non-invasive molecular imaging device for point-of-care assessment of suspicious moles

  • by Helen Bristow

  • February 10, 2026

  • 4 min

Related Content

Cutaneous SCC Trends Across Sex and Age

Researchers examine how patterns of common skin cancers vary across populations and body sites over time.

Topical 5-FU as First-Line Bowen’s Therapy

Selecting treatment for Bowen’s disease: where topical 5-fluorouracil fits

Study Explores Impact of Cannabis Extract on Melanoma Cells

The cannabis extract cannabinoid PHEC-66 may effectively treat melanoma.